Larvol Delta - Aspen-Neuroscience-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-ANPD001-Autologous-Cell-Therapy-for-the-Treatment-of-Parkinson39s-Disease

ANPD001 - Aspen Neurosci

https://www.prnewswire.com/news-releases/aspen-neuroscience-announces-fda-clearance-of-investigational-new-drug-application-for-anpd001-autologous-cell-therapy-for-the-treatment-of-parkinsons-disease-301895361.html

Aug 8, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next